BRPI0513133A - composições farmacêuticas, que contêm diaminooxidase - Google Patents

composições farmacêuticas, que contêm diaminooxidase

Info

Publication number
BRPI0513133A
BRPI0513133A BRPI0513133-2A BRPI0513133A BRPI0513133A BR PI0513133 A BRPI0513133 A BR PI0513133A BR PI0513133 A BRPI0513133 A BR PI0513133A BR PI0513133 A BRPI0513133 A BR PI0513133A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
compositions containing
containing diamino
diamino oxidase
oxidase
Prior art date
Application number
BRPI0513133-2A
Other languages
English (en)
Inventor
Albert Missbichler
Franz Gabor
Herwig Reichl
Original Assignee
Albert Missbichler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0513133(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Albert Missbichler filed Critical Albert Missbichler
Publication of BRPI0513133A publication Critical patent/BRPI0513133A/pt
Publication of BRPI0513133B1 publication Critical patent/BRPI0513133B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)

Abstract

COMPOSIçõES FARMACêUTICAS, QUE CONTêM DIAMINOOXIDASE. A presente invenção refere-se às composições farmacêuticas, composições de suplemento alimentício e cosméticas abrangendo diaminooxidase e seu uso.
BRPI0513133A 2004-07-07 2005-07-06 composição farmacêutica e usos de diaminooxidase BRPI0513133B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0115004A AT502098B8 (de) 2004-07-07 2004-07-07 Diaminooxidase-hältige zusammensetzung
PCT/EP2005/053234 WO2006003213A1 (de) 2004-07-07 2005-07-06 Pharmazeutische zusammensetzungen, die diaminooxidase enthalten

Publications (2)

Publication Number Publication Date
BRPI0513133A true BRPI0513133A (pt) 2008-04-29
BRPI0513133B1 BRPI0513133B1 (pt) 2016-12-27

Family

ID=34971770

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513133A BRPI0513133B1 (pt) 2004-07-07 2005-07-06 composição farmacêutica e usos de diaminooxidase

Country Status (20)

Country Link
US (3) US20080193491A1 (pt)
EP (2) EP1763363B1 (pt)
JP (1) JP4959558B2 (pt)
KR (1) KR101367232B1 (pt)
CN (1) CN1980689A (pt)
AT (4) AT502098B8 (pt)
AU (1) AU2005259167B2 (pt)
BR (1) BRPI0513133B1 (pt)
CA (1) CA2571463C (pt)
CY (1) CY1109351T1 (pt)
DE (2) DE502005009568D1 (pt)
DK (1) DK1763363T3 (pt)
ES (1) ES2326421T3 (pt)
HR (1) HRP20090447T1 (pt)
MX (1) MXPA06015036A (pt)
PL (1) PL1763363T3 (pt)
PT (1) PT1763363E (pt)
RS (1) RS51183B (pt)
SI (1) SI1763363T1 (pt)
WO (1) WO2006003213A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170020993A1 (en) * 2011-03-18 2017-01-26 Dr Healthcare España, S.L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
US20160024481A1 (en) * 2011-03-18 2016-01-28 Dr Healthcare España, S.L. Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
ES2388515B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para la prevención de los síntomas de la resaca.
ES2388395B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica.
ES2388166B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Alimentos funcionales que contienen diaminooxidasa y sus usos.
ES2387973B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor.
CA2831535C (en) 2011-04-07 2014-10-21 Histapharm Inc. Oral enzyme compositions for intestinal delivery
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
EP3728061A4 (en) * 2017-12-21 2021-09-08 Pepsico Inc MULTI-INGREDIENT POP-UP DRINK CAPSULE FOR PREPARING A DRINK
US20220145269A1 (en) 2019-02-19 2022-05-12 Medizinische Universität Wien New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB479487A (en) * 1935-08-01 1938-02-04 Ig Farbenindustrie Ag Manufacture of stable therapeutic products from intestinal mucous membrane
NL6815177A (pt) * 1968-10-24 1970-04-28
GB1318884A (en) * 1969-07-29 1973-05-31 Hydrovane Compressor Rotary compressors
FR2101095A1 (en) * 1970-08-20 1972-03-31 Merieux Inst Diamine oxidase from human placenta - for treatment of hyperhistamina
US3639579A (en) * 1970-12-10 1972-02-01 Matthew C Urbin Pharmaceutical preparation
FR2215944A1 (en) * 1973-02-01 1974-08-30 Bellon Labor Sa Roger Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
GB8319540D0 (en) * 1983-07-20 1983-08-24 Bovril Ltd Amine removal
US4725540A (en) * 1984-07-09 1988-02-16 Emil Underberg Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material
US5270033A (en) 1991-11-25 1993-12-14 Montgomery Robert E Antimicrobial composition and method of making same
IL143356A0 (en) * 1998-11-27 2002-04-21 Takada Kanji An oral formulation for gastrointestinal drug delivery
JP4839506B2 (ja) 2000-04-28 2011-12-21 ダイキン工業株式会社 ドライエッチング方法
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
IT1317067B1 (it) 2000-11-29 2003-05-26 Univ Roma Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.
WO2002066669A1 (en) * 2001-02-23 2002-08-29 Biovitrum Ab Method for purification of soluble ssao
JP2003212773A (ja) * 2002-01-04 2003-07-30 Oramon Arzneimittel Gmbh セチリジン及びロラタジンの局所医薬組成物
DE10239029A1 (de) * 2002-08-21 2004-03-04 Coty B.V. Kosmetische und dermatologische Zubereitung mit Proteinen zur Hautaufhellung
JP2004167178A (ja) * 2002-11-15 2004-06-17 Masashi Takahashi タン白質の経口投与法

Also Published As

Publication number Publication date
WO2006003213A1 (de) 2006-01-12
CA2571463C (en) 2014-12-09
US20080193491A1 (en) 2008-08-14
ATE467423T1 (de) 2010-05-15
AT502098B1 (de) 2007-04-15
SI1763363T1 (sl) 2009-10-31
US8716244B2 (en) 2014-05-06
RS51183B (sr) 2010-10-31
DE502005009568D1 (de) 2010-06-24
CA2571463A1 (en) 2006-01-12
EP1782824B1 (de) 2010-05-12
EP1782824A3 (de) 2007-07-18
MXPA06015036A (es) 2007-04-25
ATE432710T1 (de) 2009-06-15
US20140220148A1 (en) 2014-08-07
CY1109351T1 (el) 2014-07-02
AT503070A1 (de) 2007-07-15
AT502098B8 (de) 2007-06-15
ES2326421T3 (es) 2009-10-09
US20100330191A1 (en) 2010-12-30
EP1763363B1 (de) 2009-06-03
EP1763363A1 (de) 2007-03-21
KR20070032046A (ko) 2007-03-20
AT502098A1 (de) 2007-01-15
DE502005007425D1 (de) 2009-07-16
KR101367232B1 (ko) 2014-02-25
AU2005259167B2 (en) 2010-06-03
EP1782824A2 (de) 2007-05-09
JP2008505869A (ja) 2008-02-28
PT1763363E (pt) 2009-09-03
US9364437B2 (en) 2016-06-14
AU2005259167A1 (en) 2006-01-12
PL1763363T3 (pl) 2009-12-31
AT503070B1 (de) 2007-09-15
JP4959558B2 (ja) 2012-06-27
DK1763363T3 (da) 2009-09-14
HRP20090447T1 (hr) 2009-11-30
BRPI0513133B1 (pt) 2016-12-27
CN1980689A (zh) 2007-06-13

Similar Documents

Publication Publication Date Title
CY1109351T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν διαμινοοξειδαση
WO2004021968A3 (en) Solution for ungual application
GB0420888D0 (en) Compounds and uses
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
ATE432111T1 (de) Transparente kosmetische oder dermatologische formulierung
ITPD20050207A1 (it) Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
DE602006015449D1 (de) Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung
BRPI0810948A8 (pt) "composição hidratante, usos da composição e método para hidratar ou umidificar a pele"
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
WO2003105751A3 (en) NEW CURCUMIN DERIVATIVES
WO2007025229A3 (en) Compositions and their uses directed to hsp27
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
WO2008050157A3 (en) Ozonated oil formulations
FR2872431B1 (fr) Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
ATE519479T1 (de) Kosmetikum mit anti-alterungswirkung
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
WO2007003773A3 (fr) Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
BRPI0510503A (pt) compostos e composições como inibidores de catepsina s
WO2011073345A3 (en) Use of one or more pressure-sensitive adhesive compounds as agent for the treatment of sweating in humans

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: ALBERT MISSBICHLER (AT)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PET NO 020100091189 - RJ DE 29/09/2010 REAPRESENTE O DOCUMENTO DE CESSAO COM A LEGALIZACAO CONSULAR, BEM COMO A GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25A Requested transfer of rights approved

Owner name: SCIOTEC DIAGNOSTIC TECHNOLOGIES GMBH (AT)

Free format text: TRANSFERIDO DE: ALBERT MISSBICHLER

B25G Requested change of headquarter approved

Owner name: SCIOTEC DIAGNOSTIC TECHNOLOGIES GMBH (AT)

Free format text: ENDERECO ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110044732/RJ DE 03/05/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2154 DE 17/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/12/2016, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/16 (2006.01), A23L 29/00 (2016.01), A23L 29

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2521 DE 30-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.